Maxim Group Starts Opexa Therapeutics (OPXA) at Buy, $5 PT
Tweet Send to a Friend
Maxim Group initiates coverage on Opexa Therapeutics (NASDAQ: OPXA) with a Buy rating and a price target of $5.00.Analyst Jason ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE